Active Ingredient(s):Difluprednate FDA Approved: * June 23, 2008 Pharm Company: *SIRION THERAPEUTICS Category:Vision / Eye Health
Difluprednate is a corticosteroid, It is chemically a butyrate ester of 6(alpha),9(alpha)-difluoro prednisolone acetate. Accordingly, difluprednate is sometimes abbreviated DFBA, for difluoroprednisolone butyrate acetate.
On June 24, 2008, the US Food and Drug Administration (FDA) approved difluprednate for the treatment of post-operative ocular inflammation and pain. It is marketed by Alcon under the tradename Durezol.
* May have multiple approval dates, manufacturers, or labelers. 7 Discussions